Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use

BACKGROUND: Electronic monitoring of inhaled asthma therapy is suggested as the ‘gold standard’ for measuring patterns of medication use in clinical trials. The SmartTurbo (Adherium (NZ) Ltd, Auckland, New Zealand) is an electronic monitor for use with a turbuhaler device (AstraZeneca, UK). The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilcher, Janine, Shirtcliffe, Philippa, Patel, Mitesh, McKinstry, Steve, Cripps, Terrianne, Weatherall, Mark, Beasley, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Asthma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653861/
https://www.ncbi.nlm.nih.gov/pubmed/26629345
http://dx.doi.org/10.1136/bmjresp-2015-000097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653861/
https://www.ncbi.nlm.nih.gov/pubmed/26629345
http://dx.doi.org/10.1136/bmjresp-2015-000097

Ejemplares similares